Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital

Vaccine

Volumn 32, Issue 4, 2014, Pages 521-525

  Mills, Brittany ^a   Fensterheim, Leonard ^a   Taitel, Michael ^a   Cannon, Adam ^a  

^a Walgreen   (United States)

Author keywords

Neonatal health; Pertussis; Pharmacist driven program; Tdap vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; AGED; AREA COMMUNITY PHARMACY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FAMILY; FEMALE; HEALTH EDUCATION; HOSPITAL; HOSPITAL PERSONNEL; HOSPITAL PHARMACY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; PERTUSSIS; PHARMACIST; PHARMACY; PRIORITY JOURNAL; RISK FACTOR; VACCINATION; VERY ELDERLY; YOUNG ADULT;

NEONATAL HEALTH; PERTUSSIS; PHARMACIST-DRIVEN PROGRAM; TDAP VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH PROMOTION; HOSPITALS, MATERNITY; HUMANS; IMMUNIZATION PROGRAMS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PHARMACIES; PHARMACY SERVICE, HOSPITAL; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84891630004     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.035     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention Pertussis (whooping cough): outbreaks 2013, [cited 2013 March 21]; Available from: http://www.cdc.gov/pertussis/outbreaks.html.
2. Cherry J.D. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 2012, 367(August (9)):785-787.
3. Caro J.J., Getsios D., Payne K., Annemans L., Neumann P.J., Trindade E. Economic burden of pertussis and the impact of immunization. Pediatr Infect Dis J 2005, 24(May (5 Suppl.)):S48-S54.
4. Lee L.H., Pichichero M.E. Costs of illness due to Bordetella pertussis in families. Arch Fam Med 2000, 9(November-December (10)):989-996.
5. O'Brien J.A., Caro J.J. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis 2005, 5:57.
6. Lee G.M., Lebaron C., Murphy T.V., Lett S., Schauer S., Lieu T.A. Pertussis in adolescents and adults: should we vaccinate?. Pediatrics 2005, 115(June 6):1675-1684.
7. Klein N.P., Bartlett J., Rowhani-Rahbar A., Fireman B., Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012, 367(September (11)):1012-1019.
8. Misegades L.K., Winter K., Harriman K., Talarico J., Messonnier N.E., Clark T.A., et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012, 308(November (20)):2126-2132.
9. Kretsinger K., Broder K.R., Cortese M.M., Joyce M.P., Ortega-Sanchez I., Lee G.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55(December (RR-17)):1-37.
10. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007, 26(April (4)):293-299.
11. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005, 24(May (5 Suppl.)):S58-S61.
12. Heininger U., Kleemann W.J., Cherry J.D., Sudden Infant Death Syndrome Study Group A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004, 114(Jully (1)):e9-e15.
13. Lindgren C., Milerad J., Lagercrantz H. Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur J Pediatr 1997, 156(May (5)):405-409.
14. Campins-Marti M., Cheng H.K., Forsyth K., Guiso N., Halperin S., Huang L.M., et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001, 20(December (5-6)):641-646.
15. Forsyth K.D., Campins-Marti M., Caro J., Cherry J.D., Greenberg D., Guiso N., et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis 2004, 39(December (12)):1802-1809.
16. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep 2011, 60(January (1)):13-15.
17. Miller B.L., Kretsinger K., Euler G.L., Lu P.J., Ahmed F. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007. Vaccine 2011, 29(May (22)):3850-3856.
18. Blake E.W., Blair M.M., Couchenour R.L. Perceptions of pharmacists as providers of immunizations for adult patients. Pharmacotherapy 2003, 23(February (2)):248-254.
19. Taitel M., Cohen E., Duncan I., Pegus C. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations. Vaccine 2011, 29(October (45)):8073-8076.
20. Michaels N.M., Jenkins G.F., Pruss D.L., Heidrick J.E., Ferreri S.P. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program. J Am Pharm Assoc 2003, 50(May-June (3)):347-353. 2010.
21. Ramalho de Oliveira D., Brummel A.R., Miller D.B. Medication therapy management: 10years of experience in a large integrated health care system. J Manag Care Pharm 2010, 16(April (3)):185-195.
22. Benavides S., Rodriguez J.C., Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009, 43(January (1)):85-97.
23. Green B.B., Cook A.J., Ralston J.D., Fishman P.A., Catz S.L., Carlson J., et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008, 299(June (24)):2857-2867.
24. Postema A.S., Breiman R.F. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep 2000, 49(March (RR-1)):1-13.
25. Centers for Disease Control and Prevention Place of influenza vaccination among adults-United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep 2011, 60(23):781-785.
26. Sokos D.R. Pharmacists' role in increasing pneumococcal and influenza vaccination. Am J Health Syst Pharm 2005, 62(February (4)):367-377.
27. Steyer T.E., Ragucci K.R., Pearson W.S., Mainous A.G. The role of pharmacists in the delivery of influenza vaccinations. Vaccine 2004, 22(February (8)):1001-1006.
28. Van Amburgh J.A., Waite N.M., Hobson E.H., Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 2001, 21(September (9)):1115-1122.
29. Westrick S.C., Watcharadamrongkun S., Mount J.K., Breland M.L. Community pharmacy involvement in vaccine distribution and administration. Vaccine 2009, 27(May (21)):2858-2863.
30. American Pharmacists Association and Academy of Managed Care Pharmacy Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting. J Am Pharm Asssoc 2011, 51(November/December (6)):704-712.
31. Tan T.Q., Gerbie M.V. Pertussis and patient safety: implementing Tdap vaccine recommendations in hospitals. Jt Comm J Qual Patient Saf 2010, 36(April (4)):173-178.
32. Illinois Health Facilities and Services Review Board. Hospital profiles and annual bed reports. February 6, 2013 [cited February 8, 2013]; Available from:. http://www.hfsrb.illinois.gov/HospProf_ABR.htm.
33. Indiana State Department of Health. Indiana hospital discharge data files 2008 [cited 2013 February 6]; Available from:. http://www.in.gov/isdh/reports/hosp_disch_data/2008/index.htm.
34. Grabenstein J.D., Guess H.A., Hartzema A.G. People vaccinated by pharmacists: descriptive epidemiology. J Am Pharm Assoc 2001, 41(1):46-52. 2003.
35. Uscher-Pines L., Harris K.M., Burns R.M., Mehrotra A. The growth of retail clinics in vaccination delivery in the U.S. Am J Prev Med 2012, 43(July (1)):63-66.
36. Immunization Action Coalition. State information: Tdap booster requirements for secondary schools. November 1, 2012 [cited 2013 April 17]; Available from:. http://www.immunize.org/laws/tdap.asp.
37. Klish L., Ruggero M., Lipkind H., O'Mara L., Arnold S., Topal J. Protecting Newborns from Pertussis through Improving the Rate of Post-Partum Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccination via a Pharmacist Driven Protocol. Oral abstract presented at: Pertussis Vaccines and Challenges 2011.
38. Dylag A.M., Shah S.I. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics 2008, 122(September (3)):e550-e555.
39. Camenga D.R., Kyanko K., Stepczynski J., Flaherty-Hewitt M., Curry L., Sewell D., et al. Increasing adult Tdap vaccination rates by vaccinating infant caregivers in the pediatric office. Acad Pediatr 2012, 12(January-February (1)):20-25.
40. Healy C.M., Rench M.A., Baker C.J. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011, 52(January (2)):157-162.